Todd Green

244 posts

Todd Green

@TGAllergy

VP Clin Dev & Med Affairs, DBV Technologies; Clin Assoc Prof, UPMC Children’s Hospital of Pittsburgh. Postings & opinions are my own and not DBV’s or UPMC’s.

Katılım Şubat 2017

582 Takip Edilen347 Takipçiler

Todd Green retweetledi

DBV Technologies@DBVTechnologies·11 May

We are excited to have our EPITOPE Phase 3 trial evaluating our investigational Viaskin Peanut in children 1-3 years published in The New England Journal of Medicine (@NEJM ). Watch below and read the publication here: bit.ly/3BkOd7D

English

2.5K

Todd Green retweetledi

NEJM@NEJM·11 May

In the phase 3 EPITOPE trial involving children 1 to 3 years of age with peanut allergy, epicutaneous immunotherapy by means of a peanut patch was superior to placebo in desensitizing children to peanut. nej.md/3nCVZGR #pediatrics

English

39.1K

Todd Green retweetledi

Dr. Dave Stukus@AllergyKidsDoc·11 May

We’ve seen promising safety and efficacy data for the peanut patch in children and adolescents… Great to see similar benefit in toddlers as well! Hot off the press: nejm.org/doi/full/10.10…

English

6.2K

Todd Green retweetledi

DBV Technologies@DBVTechnologies·11 May

We're proud to share that @NEJM has published our EPITOPE Phase 3 trial evaluating our investigational Viaskin Peanut in #PeanutAllergic children 1-3 years. Learn more here: bit.ly/3LSkGXG

English

3.1K

Todd Green retweetledi

DBV Technologies@DBVTechnologies·20 Nis

We are pleased to announce FDA provided pre-BLA written response on regulatory path for Viaskin Peanut patch in 1-3 year olds with confirmed peanut allergy. Read more here: bit.ly/40mXc24

English

95.6K

Todd Green retweetledi

DBV Technologies@DBVTechnologies·8 Mar

We are excited to announce the first patient screened in our VITESSE Phase 3 clinical trial in #PeanutAllergic children 4-7 years old. Read more about our trial here: bit.ly/3L6u77i

English

102.4K

Todd Green retweetledi

Brian Vickery@ATLergist·10 Mar

Looking forward to launching this trial soon at @EmoryPediatrics & @childrensatl @AtlPedsResearch! ATL families with peanut allergic kids aged 4-7, take note:

DBV Technologies@DBVTechnologies

We are excited to announce the first patient screened in our VITESSE Phase 3 clinical trial in #PeanutAllergic children 4-7 years old. Read more about our trial here: bit.ly/3L6u77i

English

889

Todd Green retweetledi

Kevin Pho, M.D.@kevinmd·16 Şub

Food allergy tragedies: the reality that haunts us dlvr.it/SjWhPW #Conditions #AllergiesImmunology via @kevinmd

English

12.8K

Todd Green retweetledi

George du Toit@GoAllergy·12 Kas

Gideon Lack and @jandrewbird talking to early peanut introduction for peanut allergy prevention - #ACAAI22

English

Todd Green@TGAllergy·7 Eki

Couldn’t agree more- congratulations, Geoff!

English

Todd Green@TGAllergy·27 Eyl

Agree! @ACAAI @AllergyKidsDoc

Dr. Dave Stukus@AllergyKidsDoc

The one and only Dr. Cox (aka @JohnCMcGinley 😆) does a great job in this video discussing how and why allergists can help👏 Love the awareness campaign by @ACAAI vimeo.com/745071333

English

Todd Green retweetledi

Mary McHenry MD@maryjmchenry·22 Eyl

Dr Greenhawt reviews emerging research on treatment of peanut allergy #NAPAAC22

English

Todd Green@TGAllergy·22 Eyl

@IFPIES

Dr. Douglas Mack@DrDougMackMD

#napaac22 @nowak_wegrzyn FPIES just this year had NIAID FPIES workshop - first ever!

QAM

Todd Green retweetledi

JACI In Practice@JACIInPractice·30 Ağu

In Press! The Impact of #Allergy #Specialty #Care on #Healthcare #Utilization #Among #Peanut #Allergy #Children in the #United #States buff.ly/3e7rVh2

English

Todd Green retweetledi

AAAAI@AAAAI_org·30 Ağu

A new study in @JACIInPractice shows patients with #PeanutAllergy who receive care from an allergist experience significantly lower total mean costs than those who do not see a specialist. ow.ly/G4AH50KvMaM

English

Todd Green@TGAllergy·26 Ağu

Glad to be a part of this study demonstrating the value of allergist/immunologist care @JACIInPractice @AAAAI_org @ACAAI @wheezemd

Healio Allergy and Asthma@HealioAllergy

Despite greater severity of disease, patients with peanut #allergy experience lower total mean health care costs than those with other food allergies, said researchers at @ChildrensColo. Also, @ruchisgupta of @cfaarnu shares her perspective. #foodallergy bit.ly/3TafoJU

English

Todd Green retweetledi

Healio Allergy and Asthma@HealioAllergy·25 Ağu

English

Todd Green retweetledi

Healio Allergy and Asthma@HealioAllergy·26 Ağu

Patients with peanut #allergy who receive care from an allergist experience significantly lower total mean costs than those who do not see a specialist, said researchers at @ChildrensColo. Also, @ruchisgupta of @NUFeinbergMed shares her perspective. bit.ly/3TafoJU

English

Todd Green retweetledi

JACI In Practice@JACIInPractice·26 Ağu

Read results from the Phase 3 REALISE trial studying the safety and tolerability of epicutaneous immunotherapy with investigational patch treatment in children, supporting its continued investigation as a new potential treatment option for peanut allergy. bit.ly/3cnGJYG

English

Todd Green retweetledi

Medscape@Medscape·6 Ağu

Why in-flight emergency kits need an update ms.spr.ly/6011j3QRF

English

Keşfet

@NEJM @EmoryPediatrics @childrensatl @AtlPedsResearch @kevinmd @jandrewbird @ACAAI @AllergyKidsDoc